Business Segments Myriad Genetics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 12:00:13 2026-01-21 pm EST			5-day change	1st Jan Change
5.765 ^USD	+1.50%		-5.56%	-6.18%

Jan. 14	Myriad Genetics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 05:15 PM
Jan. 12	Myriad Genetics, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 and 2026	CI

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (USD)

Fiscal Period: December	2020	2021	2022	2023	2024
Biological Products
Biotechnology	-	691M	678M	753M	838M
Total Assets	-	1.32B	1.2B	1.15B	1.03B
Interest Expense	-	-6.6M	-3.2M	-2.9M	-2.8M
Income Tax Expense	-	-29.9M	-28.6M	1.1M	3.8M
CAPEX	-	-18M	-45.3M	-63.2M	-19M
EBT	-	-57.1M	-141M	-262M	-124M
Gross Profit	-	-	-	-	585M
D&A	-	62.8M	52.7M	61.9M	61.2M
Operating Income	-	-190M	-141M	-257M	-124M
Net Income	-	-27.2M	-112M	-263M	-127M
Other	56.2M	-	-	-	-
Total Assets	253M	-	-	-	-
D&A	4.6M	-	-	-	-
Operating Income	-173M	-	-	-	-
Total Assets	172M	-	-	-	-
Medical Testing, Analyzing, and Diagnostic Equipment
Diagnostics	543M	-	-	-	-
Total Assets	994M	-	-	-	-
D&A	67M	-	-	-	-
Operating Income	-2.8M	-	-	-	-

Geographical breakdown of sales (USD)

Fiscal Period: December	2020	2021	2022	2023	2024
United States	551M	604M	592M	118M	770M
Total Assets	1.19B	871M	983M	962M	728M
Rest of world	48.8M	86.9M	86.9M	1.3M	68.1M
Total Assets	56.8M	51.1M	45.6M	44M	1.4M
Total Assets	-	-	-	-	-
Total Assets	172M	399M	170M	141M	-